← Contracts
PT
1550/2025- Ajuste direto para aquisição de B771- Bevacizumab [25 mg/ml; 400 mg/ 16 ml; conc p/a sol p/a perfusão; frs] doentes em tratamento, U41- Ustecinumab [45 mg/ 0,5 ml; sol inj; seringa] - doentes em tratamento e U42- Ustecinumab [90 mg; sol inj; seringa] - doentes em tratamento.
ID 11525845
· Portal BASE
Price
Base Price
€342,030
.00
Effective Price
€7,800
.00
-97.7%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Setúbal, Barreiro
- Bidder Count
- —
Winner
CICLUM FARMA UNIPESSOAL, LDA
NIF 504362674
Dates
- Publication
- 18 Jun 2025
- Celebration
- 28 May 2025
Contracting Entity
Centro Hospitalar Barreiro Montijo, EPE
NIF 509186998
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 1
- Supplier
- 366
- Number of Awards
- 6
- Rule
- A1 repeat direct award: 6 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 18 Jun 2025
- Signing Date
- 28 May 2025
- Days Late
- 21
- Rule
- A2/A3 late publication: 21 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 342030.0
- Total effective price
- 7800.0
- Ratio
- 0.0228
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0228 outside [0.5, 1.5]
Detected 2026-03-06